Opterion: a disruptive dialysis treatment





- Jan 16
- 1 min
VALUEx Klosters 2023


- Oct 1, 2022
- 7 min
Excerpt 2022 interim letter

- Jun 1, 2022
- 1 min
VALUEx Vail 2022


- Apr 2, 2022
- 1 min
Omaha 2022


- Apr 1, 2022
- 2 min
Excerpt 2021 annual letter

- Jan 30, 2022
- 1 min
VALUEx Klosters 2022


- Jul 12, 2021
- 6 min
Excerpt 2021 semi-annual letter


- Jan 1, 2021
- 3 min
Excerpt 2020 annual letter


- Jul 14, 2020
- 4 min
Excerpt 2020 semi-annual letter


- Mar 1, 2020
- 7 min
Excerpt 2019 letter

- Jan 15, 2020
- 1 min
World Economic Forum: The Future of Intelligent Investing

- Oct 24, 2019
- 1 min
Upcoming conferences: VALUEx Klosters 2020


- Apr 1, 2019
- 4 min
Excerpt Q1 2019 letter


- Sep 30, 2018
- 1 min
Celebrating iolite’s 10th anniversary – a few thank yous


- Jul 1, 2018
- 6 min
Excerpt Q2 2018 letter


- Jun 5, 2018
- 1 min
Guy Spier: “With whom I would invest?”


- Feb 14, 2018
- 8 min
Forbes interview: Why This Danish Salmon Company’s Stock Price Could Double

- Jan 7, 2018
- 1 min
Upcoming conferences: MOI Global – Best Ideas 2018 (Jan 11-13)


- Sep 20, 2017
- 1 min
Upcoming conferences: VALUEx 2018 and Ideaweek 2018
Safe harbor
iolite does not engage in general solicitation. Investments may only be made by financially sophisticated individuals who have a pre-existing relationship with iolite and meet certain investment standards. No securities are available for sale through this website and nothing on this website shall constitute an offer or a solicitation for the sale of any security.